Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.888
+0.018 (0.94%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Cocrystal Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | - | - | - | - | 2.01 | 6.56 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | -69.32% | - | Upgrade
|
| Cost of Revenue | 15.72 | 15.17 | 12.39 | 8.79 | 6.03 | 4 | Upgrade
|
| Gross Profit | -15.72 | -15.17 | -12.39 | -8.79 | -4.02 | 2.56 | Upgrade
|
| Selling, General & Admin | 5.6 | 5.99 | 5.75 | 5.43 | 5.57 | 4.86 | Upgrade
|
| Operating Expenses | 5.6 | 5.99 | 5.75 | 5.43 | 5.57 | 4.86 | Upgrade
|
| Operating Income | -21.32 | -21.16 | -18.14 | -14.22 | -9.59 | -2.3 | Upgrade
|
| Interest Expense | - | - | -0 | -0 | -0.01 | -0.02 | Upgrade
|
| Interest & Investment Income | 0.87 | 0.64 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.08 | -0.07 | -0.02 | -0.01 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | 0.01 | 0.05 | -0.05 | 0.26 | Upgrade
|
| EBT Excluding Unusual Items | -20.53 | -20.58 | -18.15 | -14.19 | -9.65 | -2.07 | Upgrade
|
| Impairment of Goodwill | - | - | -19.09 | - | - | -46.1 | Upgrade
|
| Legal Settlements | 2.6 | 2.6 | -1.6 | - | - | - | Upgrade
|
| Pretax Income | -17.93 | -17.98 | -38.84 | -14.19 | -9.65 | -48.17 | Upgrade
|
| Net Income | -17.93 | -17.98 | -38.84 | -14.19 | -9.65 | -48.17 | Upgrade
|
| Net Income to Common | -17.93 | -17.98 | -38.84 | -14.19 | -9.65 | -48.17 | Upgrade
|
| Shares Outstanding (Basic) | 10 | 10 | 8 | 7 | 5 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 10 | 8 | 7 | 5 | 3 | Upgrade
|
| Shares Change (YoY) | 18.06% | 18.52% | 10.58% | 60.04% | 73.32% | 13.75% | Upgrade
|
| EPS (Basic) | -1.76 | -1.86 | -4.77 | -1.93 | -2.10 | -18.14 | Upgrade
|
| EPS (Diluted) | -1.76 | -1.86 | -4.77 | -1.93 | -2.10 | -18.14 | Upgrade
|
| Free Cash Flow | -14.28 | -14.78 | -21.51 | -12.77 | -10.07 | -1.71 | Upgrade
|
| Free Cash Flow Per Share | -1.40 | -1.53 | -2.64 | -1.73 | -2.19 | -0.64 | Upgrade
|
| Gross Margin | - | - | - | - | -199.60% | 39.00% | Upgrade
|
| Operating Margin | - | - | - | - | -475.97% | -35.09% | Upgrade
|
| Profit Margin | - | - | - | - | -479.05% | -733.84% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | -500.00% | -26.02% | Upgrade
|
| EBITDA | -21.15 | -20.97 | -17.95 | -14.03 | -9.43 | -2.21 | Upgrade
|
| EBITDA Margin | - | - | - | - | - | -33.59% | Upgrade
|
| D&A For EBITDA | 0.16 | 0.19 | 0.19 | 0.19 | 0.16 | 0.1 | Upgrade
|
| EBIT | -21.32 | -21.16 | -18.14 | -14.22 | -9.59 | -2.3 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -35.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.